NASDAQABEO

phototechno Abeona Therapeutics (NASDAQ:ABEO) traded higher on Thursday after the company announced a partnership with eye care drug developer Beacon to evaluate its patented technology, AAV204, for gene therapies. Per the terms, Beacon, which belongs to Syncona’s clinical portfolio of companies, will have a non-exclusive right to evaluate AAV204 capsidContinue Reading